Blainville sur l'Eau, France

Pierre Warnault

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Temisis. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Warnault. Retrieved from https://idiyas.com/inventor/pierre-warnault

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre Warnault: Innovator in Pharmaceutical Chemistry

Introduction

Pierre Warnault, an accomplished inventor based in Blainville sur l'Eau, France, has made significant contributions to the field of pharmaceutical chemistry. His innovative work focuses on developing compounds that have potential uses in treating inflammation and related diseases.

Latest Patents

Pierre holds a notable patent titled "Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof." This invention involves amide derivatives of polysubstituted quinic acids and provides a novel approach to creating medications aimed at mitigating inflammatory conditions. The patent outlines a specific formula and process for synthesizing these compounds, emphasizing their potential therapeutic applications.

Career Highlights

Pierre Warnault's career is marked by his commitment to advancing medical science through innovation. Working at Temisis, he has collaborated on various research projects that bridge chemistry and healthcare. His contributions have been pivotal in enhancing the understanding of polycaffeoylquinic acids and their derivatives.

Collaborations

One of Pierre's key collaborators is Damien Boeglin, with whom he has partnered to further explore the applications of his patented compounds. Their combined expertise aims to push the boundaries of how these substances can be used in pharmaceuticals, cosmetics, and nutraceuticals, ultimately leading to better health outcomes.

Conclusion

With his patent and ongoing work, Pierre Warnault continues to exemplify the spirit of innovation in the pharmaceutical sector. His research not only enhances scientific knowledge but also paves the way for new treatments that could significantly impact the management of inflammatory disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…